I. Composition/function.
A. Introduction.
- 8% body volume; specialized connective tissue where cells are formed elements and plasma is extracellular matrix (ECM); the two ECM components are ground substance (serum) and fibers (soluble fibrinogen)
B. Composition.
1. Formed elements (42% in females, 45% in males)
a. RBC - 99.9% of formed elementsb. WBC
c. platelets
2. Plasma (58% for women, 55% for men)
a. waterb. plasma proteins
c. other solutes
C. Functions of blood
II. Blood plasma.
A. Composition.
1. Water: 90-92%.
2. Solutes.
a. Proteins 7-8%(i) albumins (60%): allow fluid to be retained in circulatory system(ii) globulins (36%)
- antibodies
(iii) clotting proteins (4%)
(iv) other plasma proteins: hormones, enzymes
b. "other solutes"
- nutrients
- ions
- respiratory gases
III. Formed elements: erythrocytes, leukocytes, platelets
- all produced in bone marrow in adult from a pluripotent stem cell (PPSC); PPSC gives rise to myeloid stem cells (MSC) or lymphoid stem cells (LSC); MSC will give rise to RBC, WBC, platelets; LSC gives rise to lymphocytes
A. Erythrocytes: have biconcave shape which gives them a huge surface area relative to volume; lack nucleus, organelles, contain predominantly hemoglobin
1. Function of gas transport
- a function of hemoglobin which binds easily to oxygen
a. Structure of hemoglobin(i) globin is protein unit: four polypeptide chains, each bound to heme group(ii) heme is a complex ring structure which has atom of iron in its center; iron binds reversibly to oxygen
b. Oxygen transport
- a hemoglobin molecule can transport 4 molecules of oxygen; most of oxygen in blood is bound to hemoglobin
c. has a role in carbon dioxide transport
2. Production of erythrocytes (erythropoiesis)
- occurs in bone marrow
- stem cell becomes committed to becoming RBC by environmental signal -- begins producing and storing large amount s of hemoglobin
3. Erythropoiesis.
a. Hormonal control.- occurs by differential release of erythropoietin (EPO) by kidneys in response to changing levels of O2 in blood
- EPO release stimulated by low O2 levels in blood
4. Destruction of erythrocytes
- usually occurs in large circulatory channels (spleen, liver)
- as cells age, they become abnormally shaped, fragment engulfed by macrophages; iron and amino acids are recycled, heme used for synthesis of bile by liver
5. Erythrocyte disorders - anemias: conditions in which blood has abnormally low O2 carrying capacity; a symptom of a disorder, can have several causes
a. Insufficient number of RBC
- hemorrhagic anemias
- hemolytic anemias
b. Decreases in Hb content
- iron-deficiency anemia
- pernicious anemia
c. Abnormal hemoglobin
- thalassemias
- sickle cell anemia
6. Erythrocyte disorders - polycythemias: abnormal excess of erythrocytes, increased blood viscosity
- polycythemia vera
- secondary polycythemias
B. Leukocytes: true cells, granulocytes and agranulocytes
- function in body defense against pathogens
- characteristics:
1. Granulocytes: contain specialized membrane-bound granules, lobed nuclei; all originate from MSC
a. Neutrophils: most common WBC, have a mix of basophilic and acidophilic granules- first WBC to arrive at site of infection, very mobile; engulfs pathogen
- very effective against bacteria
b. Eosinophils: have acidophilic granules
- granules have a special variety of digestive enzymes lacking those that can digest bacteria
- primary mode of attack involves exocytosis of toxic compounds onto target surface (multicellular organism too large to be phagocytosed, parasitic worms.
c. Basophils: rarest WBC.
- cytoplasm contains histamine
- migrate to site of injury, cross capillary endothelium, discharge granules - histamine release.
2. Agranulocytes: lack obvious granules, have kidney-shaped or round nuclei.
a. Lymphocytes: have very large spherical nuclei with small rim of cytoplasm.- most found in lymph nodes, spleen, marrow.
- participate in immune response, T-lymphocytes in cell-mediated immunity, B-lymphocytes in humoral immunity.
b. Monocytes: the largest WBC, large nucleus, kidney-shaped.
- only remain in circulation for 24 hours, enter peripheral tissues where they mature into macrophages. the body's greatest scavengers; very aggressive phagocytic cells.
- when encounter invader release many chemotaxic and growth factors that attract other WBCs and stimulate tissue repair.
- important participants of immune response.
3. Production of leukocytes (leukopoiesis).
- hormonally stimulated.
- body's internal environment dictates relative numbers of WBC produced at a given point
4. Leukocyte disorders.
- Leukemia: excessive production of abnormal leukocytes- renegade leukocytes member of one clone, remain unspecialized, mitotic, suppress and impair marrow function.
- named according to abnormal cell type primarily involved; myelocytic leukemia, lymphocytic leukemia.
- acute leukemia: (quick advancing), derived from blast-type cells like lymphoblast; usually affects children.
- chronic leukemia: (slow advancing), involves proliferation of later cell stages, more common in elderly people.
5. Platelets.
- not cells in the strict sense, cytoplasmic fragments of extremely large cells called megakaryocytes.
- contains many substances that aid in clotting processes such as calcium ions, serotonin, a variety of enzymes, ADP
- are essential for clotting when blood vessels are ruptured or the lining is injured.
A. Hemostasis:
- prevents blood loss through walls of damages vessels, establishes a framework for tissue repair.
1. Vascular spasms: damage to the blood vessel walls causes constriction of vessel walls
- due to damage vessel wall becomes sticky
- platelets attach, adhere
2. Platelet plug formation:
- platelets begin to attach -- platelet adhesion.
- as platelets adhere they become activated, more platelets attach, platelet aggregation.
- how does platelet activation lead to platelet aggregation?
- activated platelets begin synthesizing and releasing many substances that further attract other platelets
- ADP
- serotonin
3. Coagulation: blood clotting.
- complex series of steps involving many factors that lead to the conversion of circulating soluble clotting proteins (fibrinogen) into insoluble protein fibrin
- fibrin covers the surface of platelet plug and forms a blood clot
PHASE 1: (2 pathways)
- intrinsic pathway: activated platelets produce factors that lead to production of prothrombin activator
- extrinsic pathway: injured tissue produces factors that lead to production of prothrombin activator
PHASE 2: common; prothrombin --> thrombin catalyzed by prothrombin activator.
PHASE 3: fibrinogen --> fibrin
B. Clot retraction & repair
- within 30-60 minutes, a clot is stabilized further by the platelet induced process of clot retraction.
- effects of clot retraction: pulls the edges of the vessel together, lowers the residual bleeding, and stabilizes the injury site; also reduces the size of the damaged area.
C. Fibrinolysis.
- a process that removes unneeded clots when permanent healing has occurred
- clot "buster" is a fibrin-digesting enzyme, plasmin; produced by activation of a proenzyme plasminogen that was incorporated in large amounts into a forming clot, remains inactive until the appropriate signals reach it.
- the presence of clots in/around blood vessels are detected by surrounding cells lining blood vessel that release tissue plasminogen activator (t-PA)
- plasmin digests fibrin strands